CLAIRYG

Polyvalent human immunoglobulin to be administered parenterally, subcutaneously or intravenously, by health care workers in hospitals and clinics, in outpatient clinics and during external consultations, in medical practices and by self-administration for the treatment of congenital or acquired immunodeficiencies or to provide immunomodulation